Top Buy
| Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 51 | 0 | 5 | 0 | 683,50 € | 759,34 € | 11,10 % |
| Boston Scientific | 46 | 0 | 10 | 0 | 68,00 € | 72,96 € | 7,29 % |
| Biogen Inc. | 45 | 2 | 5 | 1 | 202,10 € | 294,01 € | 45,48 % |
| Vertex Pharmaceuticals Inc. | 41 | 2 | 5 | 0 | 372,60 € | 382,71 € | 2,71 % |
| Alnylam Pharmace. | 36 | 0 | 3 | 0 | 141,60 € | 228,30 € | 61,23 % |
| Intuitive Surgical Inc | 34 | 0 | 3 | 0 | 354,20 € | 370,00 € | 4,46 % |
| Regeneron Pharmaceuticals Inc. | 34 | 1 | 6 | 1 | 889,20 € | 957,22 € | 7,65 % |
| UnitedHealth Group Inc. | 33 | 1 | 5 | 0 | 457,55 € | 543,72 € | 18,83 % |
| Johnson & Johnson | 31 | 1 | 2 | 0 | 138,72 € | 196,36 € | 41,55 % |
| Tenet Healthcare | 28 | 0 | 7 | 0 | 112,00 € | 121,67 € | 8,63 % |
| Merck & Co. Inc. | 28 | 1 | 2 | 0 | 118,60 € | 124,92 € | 5,33 % |
| Pfizer Inc. | 31 | 4 | 3 | 1 | 25,85 € | 41,10 € | 59,01 % |
| Neurocrine Bioscience | 27 | 0 | 7 | 0 | 130,70 € | 140,34 € | 7,38 % |
| Thermo Fisher Scientific Inc. | 26 | 0 | 5 | 0 | 531,60 € | 566,65 € | 6,59 % |
| Edwards Lifesciences Corp. | 25 | 1 | 3 | 0 | 79,20 € | 87,48 € | 10,45 % |
| Humana Inc. | 23 | 0 | 4 | 0 | 297,80 € | 439,88 € | 47,71 % |
| Amgen Inc. | 23 | 0 | 4 | 0 | 289,20 € | 298,90 € | 3,35 % |
| Cytokinetics Inc. | 24 | 1 | 3 | 0 | 61,00 € | 83,81 € | 37,40 % |
| Intra-Cellular Therapies Inc. | 23 | 0 | 6 | 0 | 64,00 € | 79,43 € | 24,11 % |
| Stryker Corp. | 23 | 0 | 8 | 0 | 305,20 € | 335,03 € | 9,77 % |
| HCA Holdings Inc. | 22 | 0 | 6 | 0 | 285,90 € | 294,53 € | 3,02 % |
| AbbVie Inc. | 21 | 0 | 4 | 0 | 152,18 € | 174,43 € | 14,62 % |
| Zoetis Inc. A | 21 | 1 | 3 | 1 | 155,28 € | 200,06 € | 28,84 % |
| BioMarin Pharmaceutical Inc. | 20 | 0 | 3 | 0 | 76,62 € | 102,62 € | 33,93 % |
| Resmed Inc. | 19 | 0 | 3 | 0 | 201,60 € | 207,72 € | 3,03 % |